Skip to content

For in vitro research use only. Not for human or animal consumption.

VaultLabs logo

Compound comparison

RETA/CAG vs Retatrutide

RETA/CAG (research blends) and Retatrutide (metabolic pathway research) sit in different research categories, so this comparison is about specifications and handling rather than interchangeability. It covers supplied form, storage requirements, published identifiers and VaultLabs catalog status. Research context only — no dosing, protocol or human-use guidance.

Research use only. For in vitro research use only. Not for human or animal consumption. Not for human consumption, medical use, or personal application.

AttributeRETA/CAGRetatrutide
CategoryResearch blendsMetabolic pathway research
Compound typeDual-peptide research blendMulti-receptor agonist peptide (research literature)
Supplied formLyophilized blend powderLyophilized powder (GLP-3 RT 10 mg / 20 mg presentations)
AppearanceWhite to off-white lyophilized materialWhite to off-white lyophilized material
Storage temperature2–8 °C (lyophilized, sealed)2–8 °C (lyophilized, sealed)
Primary research areaMulti-component incretin / amylin-pathway documentationReceptor binding assays
Also referenced asRetatrutide + cagrilintide blend, RETA CAG 15mg, retatrutide cagrilintideGLP-3 RT, Reta, RETA (colloquial for retatrutide)
Batch verificationLot lookup availableLot lookup available
VaultLabs catalog1 catalog SKU6 catalog SKUs

Shared research areas

  • No overlapping research areas are published for these two compounds — see the individual compound pages for each one's literature context.

Key differences

  • Different research categories — RETA/CAG is catalogued under research blends, Retatrutide under metabolic pathway research.
  • Material type differs — RETA/CAG is supplied as dual-peptide research blend, Retatrutide as multi-receptor agonist peptide (research literature).
  • Presentation differs — Lyophilized blend powder vs Lyophilized powder (GLP-3 RT 10 mg / 20 mg presentations).
  • Primary literature focus — Multi-component incretin / amylin-pathway documentation vs Receptor binding assays.

Storage comparison

Both are stored at 2–8 °C (lyophilized, sealed), so they can share the same cold-chain and inventory conditions. RETA/CAG: 2–8 °C sealed; follow product page and batch COA notes. Retatrutide: 2–8 °C · protect from light.

FAQ

No. RETA/CAG is catalogued under research blends and Retatrutide under metabolic pathway research. They are compared here because laboratories evaluating one frequently review the other, not because they are equivalent.

Both are specified at 2–8 °C (lyophilized, sealed) in sealed lyophilized or supplied form, so a single storage location covers both. Always follow the condition printed on the vial label and the published COA for the lot you received.

Both. RETA/CAG is listed as 1 catalog sku and Retatrutide as 6 catalog skus, each dispatched from the UAE with lot details you can check through batch verification before ordering.

No substitution guidance is provided. Material selection belongs to the validated protocol of the receiving laboratory, which should be based on published specifications and the COA for the specific lot. VaultLabs supplies reference materials and documentation only.

No. It describes catalog specifications, supplied form, storage requirements and published research categories. VaultLabs does not provide medical, dosing or human-use information for any compound.

Catalog availability

Presentations VaultLabs currently lists, dispatched from the UAE. Check the lot against batch verification before ordering.

Related library reading